Office Based Addiction Treatment (OBAT)

COVID-19 Resources

Boston Medical Center’s Office Based Addiction Treatment (OBAT) Program was established in 2003 and currently serves over 800 patients, making it the largest hospital-based addiction treatment program in New England. The OBAT team treats patients with approved medications for substance use disorders including buprenorphine, injectable buprenorphine, injectable naltrexone, and oral naltrexone. Patients receive specialized treatment for their substance use disorder integrated within a primary care setting, allowing all their medical needs to be addressed by a team of providers. The OBAT Program has been recognized nationally and replicated within many outpatient settings, including primary care, family medicine, behavioral health, and OB/Gyn practices, among others.

Derrek Anderson speaks about how the program helped him end 30 years of heroin use.

OBAT Services

The BMC OBAT Program provides the following services to patients:

• Treatment for all types of Substance Use Disorders, including opioid, alcohol, benzodiazepine, and stimulant use disorders
• Trained addiction experts including nurses, physicians, nurse practitioners, social workers, psychiatrists, patient care coordinators, medical assistants, and recovery coaches
• Medications for Opioid Use Disorder (MOUD): buprenorphine (Suboxone), injectable buprenorphine (Sublocade), and naltrexone (Vivitrol, Revia)
• Same-day medication access
• Direct telephone access to the nursing team
• Compassionate and non-judgmental care
• Harm reduction services and resources
• Specialized services to justice-involved individuals, adolescents, pregnant and post-partum women, and those with brain injuries
• Assistance accessing social supports and other benefits (e.g., food, IDs, employment, insurance)
• Behavioral health and psychiatric services
• Access to short- and long-term birth control
• Screening and treatment options for HIV; Hepatitis A, B, and C; and Sexually Transmitted Infections (STI)    
• Overdose education and access to naloxone (Narcan)